High-throughput quantification of ochronotic pigment formation in Escherichia coli to evaluate the potency of human 4-hydroxyphenylpyruvate dioxygenase inhibitors in multi-well format
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (1139117 N, 1518619 N)
- Vrije Universiteit Brussel
This publication has 23 references indexed in Scilit:
- Pyrazolone–quinazolone hybrids: A novel class of human 4-hydroxyphenylpyruvate dioxygenase inhibitorsBioorganic & Medicinal Chemistry, 2014
- Novel bacterial bioassay for a high-throughput screening of 4-hydroxyphenylpyruvate dioxygenase inhibitorsApplied Microbiology and Biotechnology, 2014
- Recombinant protein expression in Escherichia coli: advances and challengesFrontiers in Microbiology, 2014
- Molecular characterization of vulnibactin biosynthesis in Vibrio vulnificus indicates the existence of an alternative siderophoreFrontiers in Microbiology, 2014
- Strategies for the Production of Recombinant Protein in Escherichia coliThe Protein Journal, 2013
- Multi‐Enzymatic Cascade Reactions: Overview and PerspectivesAdvanced Synthesis & Catalysis, 2011
- Burkholderia cenocepacia C5424 Produces a Pigment with Antioxidant Properties Using a Homogentisate IntermediateJournal of Bacteriology, 2007
- Whole organism biocatalysisCurrent Opinion in Chemical Biology, 2005
- The Homogentisate Pathway: a Central Catabolic Pathway Involved in the Degradation of l -Phenylalanine, l -Tyrosine, and 3-Hydroxyphenylacetate in Pseudomonas putidaJournal of Bacteriology, 2004
- Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenaseThe Lancet, 1992